Share Price and Basic Stock Data
Last Updated: December 8, 2025, 3:32 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Weizmann Ltd operates in the textile processing and texturizing industry, an essential segment within India’s vast textile landscape. As of the latest market data, the stock price stood at ₹104 with a market capitalization of ₹160 Cr. Over the past few years, Weizmann has witnessed fluctuations in its revenue, with sales reported at ₹135 Cr for FY 2023, down to ₹123 Cr in FY 2024, and projected at ₹117 Cr for FY 2025. This trend reflects the volatility often seen in the textile sector, influenced by factors such as raw material costs and changing consumer preferences. Notably, sales for the trailing twelve months (TTM) were slightly higher at ₹126 Cr, indicating a modest recovery. The quarterly sales data reveals a peak in revenue during Mar 2023 at ₹37.68 Cr, followed by a decline in subsequent quarters, suggesting potential seasonality or operational challenges. Such revenue dynamics warrant closer scrutiny from investors looking to understand the underlying drivers of business performance.
Profitability and Efficiency Metrics
Profitability metrics for Weizmann Ltd present a mixed picture. The company reported an operating profit margin (OPM) of 11.30% for the latest year, which appears reasonable within the textile processing industry. However, net profit figures have been concerning, with a net loss of ₹3 Cr projected for FY 2025, and a notable dip in earnings per share (EPS) to ₹-2.32. This stark contrast raises questions about the company’s ability to convert sales into profit effectively. The interest coverage ratio (ICR) of 18.51x indicates a strong capacity to meet interest obligations, which is a positive sign for financial health. Furthermore, the return on capital employed (ROCE) remained robust at 16.0%, demonstrating effective utilization of capital. These figures suggest that while Weizmann has a solid operational framework, it faces challenges in sustaining profitability, which could deter potential investors.
Balance Sheet Strength and Financial Ratios
Examining Weizmann Ltd’s balance sheet reveals a company that maintains a conservative leverage position, with total borrowings of ₹8 Cr against reserves of ₹48 Cr. The debt-to-equity ratio stands at a comfortable level of 0.15, suggesting that the company is not overly reliant on debt for financing its operations. However, the current ratio of 0.95 indicates a potential liquidity concern, as it suggests that current liabilities nearly match current assets. This could pose risks if unexpected expenses arise. The book value per share, reported at ₹39.28, reflects the company’s equity position, although this is down from ₹45.90 the previous year, indicating some erosion in shareholder value. The price-to-book ratio of 2.73x suggests that the market may be pricing in some growth potential, yet this could also indicate overvaluation if not supported by improving financial performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Weizmann Ltd showcases a strong promoter commitment, with promoters holding 68.34% of the equity as of Mar 2025. This significant stake can be a source of confidence for retail investors, as it aligns the interests of the management with those of the shareholders. However, the absence of foreign institutional investors (FIIs) and the relatively small public float of 31.67% may raise concerns about liquidity and broader market interest in the stock. The number of shareholders has been fluctuating, with a decline from over 9,800 in Dec 2022 to around 9,592 in Sep 2025, which could indicate waning investor sentiment or a consolidation trend among existing shareholders. Such dynamics suggest that while promoter support is strong, the overall investor base may require nurturing to enhance market confidence and attract new capital.
Outlook, Risks, and Final Insight
Looking ahead, Weizmann Ltd faces a complex landscape fraught with opportunities and risks. The textile processing industry is poised for growth as domestic and international demand rebounds; however, the company’s ability to capitalize on this potential hinges on its operational efficiency and profitability. Key risks include ongoing volatility in raw material prices and the potential for further declines in net profit, as indicated by recent financial trends. Investors should also consider the implications of the low liquidity due to the concentrated shareholding structure. Overall, while Weizmann Ltd has solid operational metrics and a committed promoter base, its future performance will depend significantly on its ability to navigate these challenges, effectively manage costs, and enhance shareholder value. Investors might adopt a cautious but optimistic stance, weighing the strengths against the risks as they evaluate their positions in this textile player.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Weizmann Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minaxi Textiles Ltd | 7.81 Cr. | 1.58 | 2.55/1.43 | 4.07 | 0.82 | 0.00 % | 2.20 % | 42.3 % | 1.00 |
| Gujarat Cotex Ltd | 12.1 Cr. | 8.49 | 24.5/6.72 | 18.3 | 5.36 | 0.00 % | 3.59 % | 3.26 % | 5.00 |
| Gini Silk Mills Ltd | 36.6 Cr. | 65.5 | 165/62.1 | 20.1 | 91.2 | 0.00 % | 3.23 % | 2.24 % | 10.0 |
| Dhanlaxmi Fabrics Ltd | 47.4 Cr. | 55.2 | 70.5/52.6 | 53.1 | 0.00 % | 8.07 % | 8.90 % | 10.0 | |
| Bluechip Tex Industries Ltd | 25.6 Cr. | 130 | 191/126 | 130 | 0.00 % | 4.77 % | 5.30 % | 10.0 | |
| Industry Average | 1,235.57 Cr | 125.90 | 71.25 | 81.67 | 0.32% | 11.05% | 12.54% | 7.18 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36.53 | 31.50 | 29.42 | 37.68 | 33.27 | 30.57 | 28.42 | 30.64 | 20.98 | 31.44 | 28.58 | 36.25 | 29.99 |
| Expenses | 33.51 | 28.19 | 26.65 | 34.20 | 28.66 | 27.01 | 25.23 | 27.25 | 18.88 | 27.64 | 24.39 | 31.20 | 26.60 |
| Operating Profit | 3.02 | 3.31 | 2.77 | 3.48 | 4.61 | 3.56 | 3.19 | 3.39 | 2.10 | 3.80 | 4.19 | 5.05 | 3.39 |
| OPM % | 8.27% | 10.51% | 9.42% | 9.24% | 13.86% | 11.65% | 11.22% | 11.06% | 10.01% | 12.09% | 14.66% | 13.93% | 11.30% |
| Other Income | 0.06 | 0.25 | 0.06 | 0.05 | 0.02 | 0.03 | 0.41 | 0.11 | 0.06 | 0.06 | 0.09 | 0.06 | 0.04 |
| Interest | 0.26 | 0.24 | 0.22 | 0.23 | 0.17 | 0.15 | 0.19 | 0.15 | 0.09 | 0.12 | 0.39 | 0.23 | 0.21 |
| Depreciation | 0.85 | 0.77 | 0.77 | 0.78 | 0.78 | 0.66 | 0.65 | 0.64 | 0.59 | 0.70 | 0.71 | 1.37 | 1.08 |
| Profit before tax | 1.97 | 2.55 | 1.84 | 2.52 | 3.68 | 2.78 | 2.76 | 2.71 | 1.48 | 3.04 | 3.18 | 3.51 | 2.14 |
| Tax % | 42.64% | 24.31% | 9.78% | 44.05% | 30.71% | 36.69% | -3.62% | 11.44% | 25.00% | 26.97% | 25.79% | 33.90% | 25.23% |
| Net Profit | 0.95 | 0.66 | 1.55 | 1.10 | 2.94 | 1.76 | 2.45 | 1.82 | 0.84 | 2.25 | 1.99 | -8.68 | 1.20 |
| EPS in Rs | 0.60 | 0.42 | 0.98 | 0.69 | 1.85 | 1.11 | 1.54 | 1.15 | 0.53 | 1.42 | 1.25 | -5.47 | 0.76 |
Last Updated: August 20, 2025, 1:15 am
Below is a detailed analysis of the quarterly data for Weizmann Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 29.99 Cr.. The value appears to be declining and may need further review. It has decreased from 36.25 Cr. (Mar 2025) to 29.99 Cr., marking a decrease of 6.26 Cr..
- For Expenses, as of Jun 2025, the value is 26.60 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 31.20 Cr. (Mar 2025) to 26.60 Cr., marking a decrease of 4.60 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.39 Cr.. The value appears to be declining and may need further review. It has decreased from 5.05 Cr. (Mar 2025) to 3.39 Cr., marking a decrease of 1.66 Cr..
- For OPM %, as of Jun 2025, the value is 11.30%. The value appears to be declining and may need further review. It has decreased from 13.93% (Mar 2025) to 11.30%, marking a decrease of 2.63%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.02 Cr..
- For Interest, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 1.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.37 Cr. (Mar 2025) to 1.08 Cr., marking a decrease of 0.29 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.14 Cr.. The value appears to be declining and may need further review. It has decreased from 3.51 Cr. (Mar 2025) to 2.14 Cr., marking a decrease of 1.37 Cr..
- For Tax %, as of Jun 2025, the value is 25.23%. The value appears to be improving (decreasing) as expected. It has decreased from 33.90% (Mar 2025) to 25.23%, marking a decrease of 8.67%.
- For Net Profit, as of Jun 2025, the value is 1.20 Cr.. The value appears strong and on an upward trend. It has increased from -8.68 Cr. (Mar 2025) to 1.20 Cr., marking an increase of 9.88 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.76. The value appears strong and on an upward trend. It has increased from -5.47 (Mar 2025) to 0.76, marking an increase of 6.23.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:08 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60 | 51 | 57 | 84 | 87 | 105 | 96 | 98 | 100 | 135 | 123 | 117 | 126 |
| Expenses | 56 | 48 | 52 | 80 | 83 | 94 | 88 | 86 | 94 | 122 | 108 | 102 | 110 |
| Operating Profit | 4 | 3 | 5 | 4 | 3 | 11 | 9 | 11 | 6 | 13 | 15 | 15 | 16 |
| OPM % | 7% | 6% | 9% | 5% | 4% | 11% | 9% | 12% | 6% | 9% | 12% | 13% | 13% |
| Other Income | 1 | 2 | 0 | 3 | 3 | 2 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 |
| Profit before tax | 3 | 3 | 4 | 6 | 5 | 11 | 6 | 8 | 5 | 9 | 12 | 11 | 12 |
| Tax % | 46% | 44% | 30% | 41% | 37% | 23% | 28% | 35% | 39% | 31% | 20% | 29% | |
| Net Profit | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 5 | 3 | 4 | 9 | -4 | -3 |
| EPS in Rs | 2.23 | 2.03 | 2.25 | 2.03 | 1.77 | 3.66 | 1.72 | 3.00 | 2.19 | 2.69 | 5.65 | -2.27 | -2.04 |
| Dividend Payout % | 22% | 25% | 22% | 25% | 28% | 14% | 580% | 17% | 23% | 19% | 9% | -22% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | -25.00% | 100.00% | -50.00% | 66.67% | -40.00% | 33.33% | 125.00% | -144.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | -25.00% | 125.00% | -150.00% | 116.67% | -106.67% | 73.33% | 91.67% | -269.44% |
Weizmann Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: December 4, 2025, 2:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 15 | 15 |
| Reserves | 43 | 42 | 45 | 65 | 101 | 68 | 53 | 57 | 50 | 49 | 57 | 45 | 48 |
| Borrowings | 9 | 2 | 0 | 0 | 1 | 3 | 19 | 17 | 18 | 12 | 8 | 11 | 8 |
| Other Liabilities | 23 | 15 | 12 | 15 | 26 | 29 | 20 | 27 | 25 | 25 | 17 | 19 | 21 |
| Total Liabilities | 92 | 75 | 74 | 97 | 145 | 117 | 109 | 118 | 109 | 102 | 97 | 91 | 92 |
| Fixed Assets | 16 | 16 | 17 | 17 | 20 | 24 | 23 | 29 | 28 | 27 | 26 | 33 | 41 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 1 |
| Investments | 10 | 12 | 12 | 30 | 68 | 58 | 47 | 44 | 43 | 36 | 35 | 22 | 21 |
| Other Assets | 65 | 47 | 46 | 50 | 57 | 36 | 37 | 45 | 39 | 39 | 35 | 35 | 28 |
| Total Assets | 92 | 75 | 74 | 97 | 145 | 117 | 109 | 118 | 109 | 102 | 97 | 91 | 92 |
Below is a detailed analysis of the balance sheet data for Weizmann Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 48.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 48.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 11.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 92.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 91.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 7.00 Cr..
- For Total Assets, as of Sep 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (48.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.00 | 1.00 | 5.00 | 4.00 | 2.00 | 8.00 | -10.00 | -6.00 | -12.00 | 1.00 | 7.00 | 4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 134 | 46 | 33 | 26 | 24 | 42 | 48 | 68 | 44 | 37 | 26 | 38 |
| Inventory Days | 141 | 73 | 86 | 38 | 88 | 60 | 72 | 100 | 66 | 60 | 89 | 95 |
| Days Payable | 98 | 130 | 85 | 61 | 111 | 182 | 161 | 196 | 176 | 140 | 109 | 148 |
| Cash Conversion Cycle | 177 | -12 | 34 | 2 | 1 | -79 | -41 | -28 | -66 | -43 | 5 | -16 |
| Working Capital Days | 214 | 203 | 192 | 117 | 130 | -12 | -42 | -18 | -49 | -22 | -2 | -7 |
| ROCE % | 7% | 4% | 7% | 8% | 5% | 11% | 7% | 9% | 4% | 12% | 16% | 16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.32 | 5.65 | 2.69 | 2.19 | 3.00 |
| Diluted EPS (Rs.) | -2.30 | 5.65 | 2.69 | 2.03 | 3.00 |
| Cash EPS (Rs.) | 7.34 | 7.76 | 5.86 | 3.95 | 4.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 39.28 | 45.90 | 40.82 | 41.76 | 43.14 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 39.28 | 45.90 | 40.82 | 41.76 | 43.14 |
| Revenue From Operations / Share (Rs.) | 75.67 | 77.50 | 85.22 | 62.95 | 56.52 |
| PBDIT / Share (Rs.) | 9.95 | 9.66 | 8.20 | 5.30 | 6.94 |
| PBIT / Share (Rs.) | 7.77 | 7.94 | 6.19 | 3.17 | 5.14 |
| PBT / Share (Rs.) | 7.24 | 7.53 | 5.59 | 3.00 | 4.39 |
| Net Profit / Share (Rs.) | 5.17 | 6.04 | 3.86 | 1.81 | 2.85 |
| NP After MI And SOA / Share (Rs.) | -2.32 | 5.65 | 2.69 | 2.19 | 3.00 |
| PBDIT Margin (%) | 13.14 | 12.46 | 9.61 | 8.42 | 12.27 |
| PBIT Margin (%) | 10.27 | 10.24 | 7.26 | 5.03 | 9.08 |
| PBT Margin (%) | 9.56 | 9.71 | 6.56 | 4.75 | 7.77 |
| Net Profit Margin (%) | 6.83 | 7.79 | 4.53 | 2.88 | 5.04 |
| NP After MI And SOA Margin (%) | -3.06 | 7.29 | 3.15 | 3.47 | 5.31 |
| Return on Networth / Equity (%) | -5.90 | 12.30 | 6.58 | 5.23 | 6.96 |
| Return on Capital Employeed (%) | 18.91 | 16.83 | 14.69 | 7.29 | 11.58 |
| Return On Assets (%) | -3.96 | 9.21 | 4.18 | 3.16 | 4.40 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.15 | 0.10 | 0.17 | 0.27 | 0.21 |
| Asset Turnover Ratio (%) | 1.25 | 1.24 | 1.28 | 0.94 | 0.92 |
| Current Ratio (X) | 0.95 | 1.02 | 0.80 | 0.72 | 0.91 |
| Quick Ratio (X) | 0.64 | 0.58 | 0.56 | 0.53 | 0.66 |
| Inventory Turnover Ratio (X) | 12.83 | 4.55 | 6.15 | 4.85 | 4.28 |
| Dividend Payout Ratio (NP) (%) | -22.05 | 8.84 | 18.61 | 24.91 | 0.00 |
| Dividend Payout Ratio (CP) (%) | -346.43 | 6.78 | 10.66 | 12.61 | 0.00 |
| Earning Retention Ratio (%) | 122.05 | 91.16 | 81.39 | 75.09 | 0.00 |
| Cash Earning Retention Ratio (%) | 446.43 | 93.22 | 89.34 | 87.39 | 0.00 |
| Interest Coverage Ratio (X) | 18.51 | 23.49 | 13.60 | 30.32 | 9.31 |
| Interest Coverage Ratio (Post Tax) (X) | 10.62 | 15.68 | 7.41 | 11.38 | 4.83 |
| Enterprise Value (Cr.) | 174.57 | 182.48 | 140.15 | 104.54 | 89.41 |
| EV / Net Operating Revenue (X) | 1.49 | 1.48 | 1.04 | 1.05 | 0.91 |
| EV / EBITDA (X) | 11.33 | 11.91 | 10.78 | 12.43 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.41 | 1.43 | 0.96 | 0.88 | 0.76 |
| Retention Ratios (%) | 122.05 | 91.15 | 81.38 | 75.08 | 0.00 |
| Price / BV (X) | 2.73 | 2.42 | 2.01 | 1.34 | 1.00 |
| Price / Net Operating Revenue (X) | 1.41 | 1.43 | 0.96 | 0.88 | 0.76 |
| EarningsYield | -0.02 | 0.05 | 0.03 | 0.03 | 0.06 |
After reviewing the key financial ratios for Weizmann Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.32. This value is below the healthy minimum of 5. It has decreased from 5.65 (Mar 24) to -2.32, marking a decrease of 7.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from 5.65 (Mar 24) to -2.30, marking a decrease of 7.95.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has decreased from 7.76 (Mar 24) to 7.34, marking a decrease of 0.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 39.28. It has decreased from 45.90 (Mar 24) to 39.28, marking a decrease of 6.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 39.28. It has decreased from 45.90 (Mar 24) to 39.28, marking a decrease of 6.62.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 75.67. It has decreased from 77.50 (Mar 24) to 75.67, marking a decrease of 1.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.95. This value is within the healthy range. It has increased from 9.66 (Mar 24) to 9.95, marking an increase of 0.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.77. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.77, marking a decrease of 0.17.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.24. This value is within the healthy range. It has decreased from 7.53 (Mar 24) to 7.24, marking a decrease of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. It has decreased from 6.04 (Mar 24) to 5.17, marking a decrease of 0.87.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.32. This value is below the healthy minimum of 2. It has decreased from 5.65 (Mar 24) to -2.32, marking a decrease of 7.97.
- For PBDIT Margin (%), as of Mar 25, the value is 13.14. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 13.14, marking an increase of 0.68.
- For PBIT Margin (%), as of Mar 25, the value is 10.27. This value is within the healthy range. It has increased from 10.24 (Mar 24) to 10.27, marking an increase of 0.03.
- For PBT Margin (%), as of Mar 25, the value is 9.56. This value is below the healthy minimum of 10. It has decreased from 9.71 (Mar 24) to 9.56, marking a decrease of 0.15.
- For Net Profit Margin (%), as of Mar 25, the value is 6.83. This value is within the healthy range. It has decreased from 7.79 (Mar 24) to 6.83, marking a decrease of 0.96.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.06. This value is below the healthy minimum of 8. It has decreased from 7.29 (Mar 24) to -3.06, marking a decrease of 10.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.90. This value is below the healthy minimum of 15. It has decreased from 12.30 (Mar 24) to -5.90, marking a decrease of 18.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.91. This value is within the healthy range. It has increased from 16.83 (Mar 24) to 18.91, marking an increase of 2.08.
- For Return On Assets (%), as of Mar 25, the value is -3.96. This value is below the healthy minimum of 5. It has decreased from 9.21 (Mar 24) to -3.96, marking a decrease of 13.17.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.15, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.25. It has increased from 1.24 (Mar 24) to 1.25, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 24) to 0.95, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.64, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 8. It has increased from 4.55 (Mar 24) to 12.83, marking an increase of 8.28.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -22.05. This value is below the healthy minimum of 20. It has decreased from 8.84 (Mar 24) to -22.05, marking a decrease of 30.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is -346.43. This value is below the healthy minimum of 20. It has decreased from 6.78 (Mar 24) to -346.43, marking a decrease of 353.21.
- For Earning Retention Ratio (%), as of Mar 25, the value is 122.05. This value exceeds the healthy maximum of 70. It has increased from 91.16 (Mar 24) to 122.05, marking an increase of 30.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 446.43. This value exceeds the healthy maximum of 70. It has increased from 93.22 (Mar 24) to 446.43, marking an increase of 353.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 18.51. This value is within the healthy range. It has decreased from 23.49 (Mar 24) to 18.51, marking a decrease of 4.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.62. This value is within the healthy range. It has decreased from 15.68 (Mar 24) to 10.62, marking a decrease of 5.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 174.57. It has decreased from 182.48 (Mar 24) to 174.57, marking a decrease of 7.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 1.49, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 11.33. This value is within the healthy range. It has decreased from 11.91 (Mar 24) to 11.33, marking a decrease of 0.58.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.41, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 122.05. This value exceeds the healthy maximum of 70. It has increased from 91.15 (Mar 24) to 122.05, marking an increase of 30.90.
- For Price / BV (X), as of Mar 25, the value is 2.73. This value is within the healthy range. It has increased from 2.42 (Mar 24) to 2.73, marking an increase of 0.31.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.41, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to -0.02, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Weizmann Ltd:
- Net Profit Margin: 6.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.91% (Industry Average ROCE: 11.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.9% (Industry Average ROE: 12.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 71.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.15
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.83%
About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Processing/Texturising | Empire House, 214, Dr. D.N. Road, Mumbai Maharashtra 400001 | investorsgrievance@weizmann.co.in http://www.weizmann.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dharmendra G Siraj | Chairman |
| Mr. Neelkamal V Siraj | Vice Chairman & Mng.Director |
| Mr. Chetan D Mehra | Director |
| Mr. Hitesh V Siraj | Director |
| Mr. Balady S Shetty | Director |
| Mrs. Smita V Davda | Director |
Weizmann Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹120.00 |
| Previous Day | ₹123.05 |
FAQ
What is the intrinsic value of Weizmann Ltd?
Weizmann Ltd's intrinsic value (as of 08 December 2025) is 25.83 which is 74.92% lower the current market price of 103.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 160 Cr. market cap, FY2025-2026 high/low of 158/88.1, reserves of ₹48 Cr, and liabilities of 92 Cr.
What is the Market Cap of Weizmann Ltd?
The Market Cap of Weizmann Ltd is 160 Cr..
What is the current Stock Price of Weizmann Ltd as on 08 December 2025?
The current stock price of Weizmann Ltd as on 08 December 2025 is 103.
What is the High / Low of Weizmann Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Weizmann Ltd stocks is 158/88.1.
What is the Stock P/E of Weizmann Ltd?
The Stock P/E of Weizmann Ltd is .
What is the Book Value of Weizmann Ltd?
The Book Value of Weizmann Ltd is 40.8.
What is the Dividend Yield of Weizmann Ltd?
The Dividend Yield of Weizmann Ltd is 0.48 %.
What is the ROCE of Weizmann Ltd?
The ROCE of Weizmann Ltd is 16.0 %.
What is the ROE of Weizmann Ltd?
The ROE of Weizmann Ltd is 5.25 %.
What is the Face Value of Weizmann Ltd?
The Face Value of Weizmann Ltd is 10.0.